Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)
Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –
Utah Medical Products total assets
Total assets on the balance sheet at the end of each period.
Utah Medical Products's total assets was $124.57M at Jun 30, 2026. For fiscal 2025 it was $122.54M, up 0.0% from the year before. Over ten years it grew 4.5% a year on average. The highest annual figure on record is $135.46M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $122.54M | +0.0% |
| FY2024 | Dec 31, 2024 | $122.54M | -9.5% |
| FY2023 | Dec 31, 2023 | $135.46M | +9.4% |
| FY2022 | Dec 31, 2022 | $123.87M | +7.1% |
| FY2021 | Dec 31, 2021 | $115.64M | +3.5% |
| FY2020 | Dec 31, 2020 | $111.75M | +1.8% |
| FY2019 | Dec 31, 2019 | $109.79M | +10.0% |
| FY2018 | Dec 31, 2018 | $99.77M | +7.6% |
| FY2017 | Dec 31, 2017 | $92.75M | +21.7% |
| FY2016 | Dec 31, 2016 | $76.19M | -3.8% |
| FY2015 | Dec 31, 2015 | $79.18M | -2.3% |
| FY2014 | Dec 31, 2014 | $81.08M | +0.5% |
| FY2013 | Dec 31, 2013 | $80.71M | +4.9% |
| FY2012 | Dec 31, 2012 | $76.94M | +0.7% |
| FY2011 | Dec 31, 2011 | $76.39M | +85.2% |
| FY2010 | Dec 31, 2010 | $41.24M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $124.57M | +3.1% |
| Q1 FY2026 | Mar 31, 2026 | $124.38M | +1.5% |
| Q4 FY2025 | Dec 31, 2025 | $122.54M | +0.0% |
| Q3 FY2025 | Sep 30, 2025 | $121.98M | -10.0% |
| Q2 FY2025 | Jun 30, 2025 | $120.80M | -8.0% |
| Q1 FY2025 | Mar 31, 2025 | $122.52M | -6.1% |
| Q4 FY2024 | Dec 31, 2024 | $122.54M | -4.1% |
| Q4 FY2023 | Dec 31, 2023 | $135.46M | +9.4% |
| Q3 FY2023 | Sep 30, 2023 | $131.24M | +10.8% |
| Q2 FY2023 | Jun 30, 2023 | $130.48M | +12.3% |
| Q1 FY2023 | Mar 31, 2023 | $127.77M | +6.7% |
| Q4 FY2022 | Dec 31, 2022 | $123.87M | +7.1% |
| Q3 FY2022 | Sep 30, 2022 | $118.41M | -1.1% |
| Q2 FY2022 | Jun 30, 2022 | $116.15M | -0.6% |
| Q1 FY2022 | Mar 31, 2022 | $119.80M | +4.7% |
| Q4 FY2021 | Dec 31, 2021 | $115.64M | +3.5% |
| Q3 FY2021 | Sep 30, 2021 | $119.75M | +11.8% |
| Q2 FY2021 | Jun 30, 2021 | $116.79M | +12.8% |
| Q1 FY2021 | Mar 31, 2021 | $114.39M | +10.8% |
| Q4 FY2020 | Dec 31, 2020 | $111.75M | +1.8% |
| Q3 FY2020 | Sep 30, 2020 | $107.07M | +2.9% |
| Q2 FY2020 | Jun 30, 2020 | $103.55M | +0.2% |
| Q1 FY2020 | Mar 31, 2020 | $103.19M | -1.8% |
| Q4 FY2019 | Dec 31, 2019 | $109.79M | +10.0% |
| Q3 FY2019 | Sep 30, 2019 | $104.09M | +5.0% |
| Q2 FY2019 | Jun 30, 2019 | $103.36M | +6.5% |
| Q1 FY2019 | Mar 31, 2019 | $105.05M | +8.1% |
| Q4 FY2018 | Dec 31, 2018 | $99.77M | +7.6% |
| Q3 FY2018 | Sep 30, 2018 | $99.15M | +9.3% |
| Q2 FY2018 | Jun 30, 2018 | $97.04M | +12.9% |
| Q1 FY2018 | Mar 31, 2018 | $97.19M | +18.3% |
| Q4 FY2017 | Dec 31, 2017 | $92.75M | +21.7% |
| Q3 FY2017 | Sep 30, 2017 | $90.68M | +9.5% |
| Q2 FY2017 | Jun 30, 2017 | $85.95M | +6.0% |
| Q1 FY2017 | Mar 31, 2017 | $82.17M | -1.3% |
| Q4 FY2016 | Dec 31, 2016 | $76.19M | -3.8% |
| Q3 FY2016 | Sep 30, 2016 | $82.82M | – |
| Q2 FY2016 | Jun 30, 2016 | $81.04M | – |
| Q1 FY2016 | Mar 31, 2016 | $83.21M | – |
| Q4 FY2015 | Dec 31, 2015 | $79.18M | – |
See a number that looks wrong?